최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기International journal of geriatric psychiatry, v.26 no.10, 2011년, pp.991 - 999
Quigley, Harriet (Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, UK) , Colloby, Sean J. (Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, UK) , O'Brien, John T.
AbstractObjectiveTo review the rapidly expanding literature of amyloid PET imaging with particular attention to Pittsburgh compound‐B (PIB) in Alzheimer's disease (AD), dementia with Lewy bodies (DLB), fronto‐temporal dementia (FTD), mild cognitive impairment (MCI) and cognitively normal...
Agdeppa ED , Kepe V , Petri A , et al . 2003 . In vitro detection of (S)‐naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2‐(1‐[6‐[(2‐[(18)F]fluoroethyl)(methyl)amino]‐2‐naphthyl]ethylidene)malononitrile . Neuroscience 117 : 723 – 730 .
Aizenstein HJ , Nebes RD , Saxton JA , et al . 2008 . Frequent amyloid deposition without significant cognitive impairment among the elderly . Arch Neurol 65 : 1509 – 1517 .
Archer HA , Edison P , Brooks DJ , et al . 2006 . Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C‐PIB positron emission tomography study . Ann Neurol 60 : 145 – 147 .
Ballard C , Ziabreva I , Perry R , et al . 2006 . Differences in neuropathologic characteristics across the Lewy body dementia spectrum . Neurology 67 : 1931 – 1934 .
Bennett DA , Schneider JA , Arvanitakis Z , et al . 2006 . Neuropathology of older persons without cognitive impairment from two community‐based studies . Neurology 66 : 1837 – 1844 .
Bornebroek M , Verzijlbergen JF , Haan J , et al . 1996 . Potential for imaging cerebral amyloid deposits using 123I‐labelled serum amyloid P component and SPET . Nucl Med Commun 17 : 929 – 933 .
Braak H , Braak E . 1991 . Neuropathological stageing of Alzheimer‐related changes . Acta Neuropathol 82 : 239 – 259 .
Brooks DJ . 2009 . Imaging amyloid in Parkinson's disease dementia and dementia with Lewy bodies with positron emission tomography . Mov Disord 24 (Suppl 2) : S742 – S747 .
Burack MA , Hartlein J , Flores HP , et al . 2010 . In vivo amyloid imaging in autopsy‐confirmed Parkinson disease with dementia . Neurology 74 : 77 – 84 .
Edison P , Archer HA , Hinz R , et al . 2007 . Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study . Neurology 68 : 501 – 508 .
Edison P , Rowe CC , Rinne JO , et al . 2008 . Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography . J Neurol Neurosurg Psychiatr 79 : 1331 – 1338 .
Engler H , Forsberg A , Almkvist O , et al . 2006 . Two‐year follow‐up of amyloid deposition in patients with Alzheimer's disease . Brain 129 : 2856 – 2866 .
Engler H , Santillo AF , Wang SX , et al . 2008 . In vivo amyloid imaging with PET in frontotemporal dementia . Eur J Nucl Med Mol Imaging 35 : 100 – 106 .
Forsberg A , Engler H , Almkvist O , et al . 2008 . PET imaging of amyloid deposition in patients with mild cognitive impairment . Neurobiol Aging 29 : 1456 – 1465 .
Friedland RP , Majocha RE , Reno JM , Lyle LR , Marotta CA . 1994 . Development of an anti‐A beta monoclonal antibody for in vivo imaging of amyloid angiopathy in Alzheimer's disease . Mol Neurobiol 9 : 107 – 113 .
Galton CJ , Patterson K , Graham K , et al . 2001 . Differing patterns of temporal atrophy in Alzheimer's disease and semantic dementia . Neurology 57 : 216 – 225 .
Gomperts SN , Rentz DM , Moran E , et al . 2008 . Imaging amyloid deposition in Lewy body diseases . Neurology 71 : 903 – 910 .
Hansson O , Zetterberg H , Buchhave P , et al . 2006 . Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow‐up study . Lancet Neurol 5 : 228 – 234 .
Hardy J , Selkoe DJ . 2002 . The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics . Science 297 : 353 – 356 .
Hardy JA , Higgins GA . 1992 . Alzheimer's disease: the amyloid cascade hypothesis . Science 256 : 184 – 185 .
Ikonomovic MD , Klunk WE , Abrahamson EE , et al . 2008 . Post‐mortem correlates of in vivo PiB‐PET amyloid imaging in a typical case of Alzheimer's disease . Brain 131 : 1630 – 1645 .
Jack CR Jr , Lowe VJ , Senjem ML , et al . 2008 . 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment . Brain 131 : 665 – 680 .
Jack CR Jr , Lowe VJ , Weigand SD , et al . 2009 . Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease . Brain 132 : 1355 – 1365 .
Joachim CL , Morris JH , Selkoe DJ . 1989 . Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease . Am J Pathol 135 : 309 – 319 .
Johnson KA , Gregas M , Becker JA , et al . 2007 . Imaging of amyloid burden and distribution in cerebral amyloid angiopathy . Ann Neurol 62 : 229 – 234 .
Kemppainen NM , Aalto S , Wilson IA , et al . 2007 . PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment . Neurology 68 : 1603 – 1606 .
Klunk WE , Engler H , Nordberg A , et al . 2004 . Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B . Annal Neurol 55 : 306 – 319 .
Klunk WE , Mathis CA . 2008 . The future of amyloid‐beta imaging: a tale of radionuclides and tracer proliferation . Curr Opin Neurol 21 : 683 – 687 .
Klunk WE , Price JC , Mathis CA , et al . 2007 . Amyloid deposition begins in the striatum of presenilin‐1 mutation carriers from two unrelated pedigrees . J Neurosci 27 : 6174 – 6184 .
Koivunen J , Pirttila T , Kemppainen N , et al . 2008 . PET amyloid ligand [11C]PIB uptake and cerebrospinal fluid beta‐amyloid in mild cognitive impairment . Dementia Geriatr Cognit Disord 26 : 378 – 383 .
Lockhart A , Lamb JR , Osredkar T , et al . 2007 . PIB is a non‐specific imaging marker of amyloid‐beta (Abeta) peptide‐related cerebral amyloidosis . Brain 130 : 2607 – 2615 .
Lopresti BJ , Klunk WE , Mathis CA , et al . 2005 . Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis . J Nucl Med 46 : 1959 – 1972 .
Lucignani G . 2009 . Clinical applications of PET amyloid imaging: an update . Eur J Nucl Med Mol Imaging 36 : 1185 – 1190 .
Maggio JE , Stimson ER , Ghilardi JR , et al . 1992 . Reversible in vitro growth of Alzheimer disease beta‐amyloid plaques by deposition of labeled amyloid peptide . Proc Natl Acad Sci USA 89 : 5462 – 5466 .
Mathis CA , Wang Y , Holt DP , et al . 2003 . Synthesis and evaluation of 11C‐labeled 6‐substituted 2‐arylbenzothiazoles as amyloid imaging agents . J Med Chem 46 : 2740 – 2754 .
Mintun MA , Larossa GN , Sheline YI , et al . 2006 . [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease . Neurology 67 : 446 – 452 .
Mormino , EC , Kluth , JT , Madison , CM , et al . 2009 . Episodic memory loss is related to hippocampal‐mediated beta‐amyloid deposition in elderly subjects . Brain 132 : 1310 – 1323 .
Morris JC , Storandt M , Miller JP , et al . 2001 . Mild cognitive impairment represents early‐stage Alzheimer disease . Arch Neurol 58 : 397 – 405 .
Nordberg A . 2004 . PET imaging of amyloid in Alzheimer's disease . Lancet Neurol 3 : 519 – 527 .
Nordberg A . 2008 . Amyloid imaging in Alzheimer's disease . Neuropsychologia 46 : 1636 – 1641 .
Pike KE , Savage G , Villemagne VL , et al . 2007 . Beta‐amyloid imaging and memory in non‐demented individuals: evidence for preclinical Alzheimer's disease . Brain 130 : 2837 – 2844 .
Poduslo JF , Wengenack TM , Curran GL , et al . 2002 . Molecular targeting of Alzheimer's amyloid plaques for contrast‐enhanced magnetic resonance imaging . Neurobiol Disease 11 : 315 – 329 .
Price JC , Klunk WE , Lopresti BJ , et al . 2005 . Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound‐B . J Cerebr Blood Flow Metabol 25 : 1528 – 1547 .
Rabinovici GD , Furst AJ , O'Neil JP , et al . 2007 . 11C‐PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration . Neurology 68 : 1205 – 1212 .
Rabinovici GD , Jagust WJ . 2009 . Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo . Behav Neurol 21 : 117 – 128 .
Reiman EM , Chen K , Liu X , et al . 2009 . Fibrillar amyloid‐beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease . Proc Natl Acad Sci USA 106 : 6820 – 6825 .
Rowe CC , Ackerman U , Browne W , et al . 2008 . Imaging of amyloid beta in Alzheimer's disease with 18F‐BAY94‐9172, a novel PET tracer: proof of mechanism . Lancet Neurol 7 : 129 – 135 .
Rowe CC , Ng S , Ackermann U , et al . 2007 . Imaging beta‐amyloid burden in aging and dementia . Neurology 68 : 1718 – 1725 .
Santens P , Petit H . 1997 . Positron emission tomography in dementia . Acta Neurol Belg 97 : 192 – 195 .
Shoghi‐Jadid K , Small GW , Agdeppa ED , et al . 2002 . Localization of neurofibrillary tangles and beta‐amyloid plaques in the brains of living patients with Alzheimer disease . Am J Geriatr Psychiatr 10 : 24 – 35 .
Small GW , Kepe V , Ercoli LM , et al . 2006 . PET of brain amyloid and tau in mild cognitive impairment . New Engl J Med 355 : 2652 – 2663 .
Stozicka Z , Zilka N , Novak M . 2007 . Risk and protective factors for sporadic Alzheimer's disease . Acta Virologica 51 : 205 – 222 .
Terry RD , Masliah E , Salmon DP , et al . 1991 . Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment . Annal Neurol 30 : 572 – 580 .
Thal DR , Rub U , Orantes M , Braak H . 2002 . Phases of A beta‐deposition in the human brain and its relevance for the development of AD . Neurology 58 : 1791 – 1800 .
Vandenberghe R , Thurfjell L , Owenius R , et al . 2008 . P1‐303: Phase I study of the 18F‐labelled benzothiazole derivative [18F]AH110690 as a biomarker of Alzheimer's disease‐related brain amyloidosis . Alzheimer's Dementia 4 : T308 – T308 .
Verhoeff NPLG , Wilson AA , Takeshita S , et al . 2004 . In‐vivo imaging of Alzheimer disease beta‐amyloid with [11C]SB‐13 PET . Am J Geriatr Psychiatr 12 : 584 – 595 .
Villemagne VL , Pike KE , Darby D , et al . 2008 . Abeta deposits in older non‐demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease . Neuropsychologia 46 : 1688 – 1697 .
Wimo A , Winblad B , Aguero‐Torres H , von Strauss E . 2003 . The magnitude of dementia occurrence in the world . Alzheimer Disease Assoc Disord 17 : 63 – 67 .
Wolk DA , Klunk W . 2009 . Update on amyloid imaging: from healthy aging to Alzheimer's disease . Curr Neurol Neurosci Rep 9 : 345 – 352 .
Wolk DA , Price JC , Saxton JA , et al . 2009 . Amyloid imaging in mild cognitive impairment subtypes . Ann Neurol 65 : 557 – 568 .
Zhuang Z‐P , Kung M‐P , Wilson A , et al . 2003 . Structure‐activity relationship of imidazo[1,2‐a]pyridines as ligands for detecting beta‐amyloid plaques in the brain . J Med Chem 46 : 237 – 243 .
※ AI-Helper는 부적절한 답변을 할 수 있습니다.